患有急性减补性心力衰竭的患者的身体功能年龄特异性变化
Yuta Nakaya1,2,3, Masanori Akamatsu1, Kaho Yakushiji1
1Department of Rehabilitation, Uwajima City Hospital.
International heart journal
|January 19, 2025
概括
心脏康复 (CR) 改善了急性不补偿性心力衰竭 (ADHF) 患者的身体功能. 尽管与年龄相关的下降,但CR在60岁以上的所有年龄组都产生了类似的功能改善.
科学领域:
- 心脏病学 心脏病学
- 老年病的医生 老年病的医生
- 康复医学 康复医学 康复医学
背景情况:
- 众所周知,心脏康复 (CR) 可以改善急性不补偿性心力衰竭 (ADHF) 和脆弱性患者的身体功能.
- 然而,有限的研究已经探索了住院期间特定年龄的身体功能变化,特别是使用多重评估措施.
- 晚年对ADHF患者CR结局的影响需要进一步阐明.
研究的目的:
- 在急性期治疗期间,对接受CR的ADHF住院患者进行年龄特异性的身体功能变化进行调查.
- 评估CR在不同年龄层 (≥60岁) 改善身体功能和脆弱性的有效性.
主要方法:
- 分析了一组531名患有ADHF的患者,年龄≥60岁,他们在2018年6月至2023年6月期间接受了CR.
- 身体功能在入院和出院时被评估,使用握力,四头肌异度强度,短物理性能电池 (SPPB),步行速度和脆弱性评估.
- 身体功能的变化在各年龄组进行了比较:60-69岁,70-79岁,80-89岁和≥90岁.
主要成果:
- 在所有测量参数中,随着年龄的增加,入院和出院时的身体功能显著下降.
- 90岁以上的患者在入院时表现出四头肌强度和SPPB分数的严重损伤.
- 尽管最初的情况有所下降,但SPPB得分和虚弱度的改善幅度在所有年龄组 (60-69岁,70-79岁,80-89岁和≥90岁) 中都相当.
结论:
- 虽然晚年与ADHF患者的基线身体功能较差有关,但CR在所有年龄组 (≥60岁) 显示出一致的好处.
- 该研究强调,CR可以有效地改善身体功能和减少虚弱,无论年龄,在老年人住院治疗ADHF.
- 这些发现支持对患有ADHF的老年患者实施CR,以优化恢复和功能结果.
相关概念视频
01:17Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
01:26Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
01:22Heart Failure Drugs: Diuretics
338
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
338
01:20Exercise and Cardiovascular Response
722
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
722
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
378
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
378
01:26Heart Failure Drugs: Inotropic Agents
511
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
511